General Information of This Drug (ID: DM1V78I)

Drug Name
MK-6096   DM1V78I
Synonyms
FILOREXANT; MK-6096; 1088991-73-4; UNII-E6BTT8VA5Z; MK6096; MK 6096; E6BTT8VA5Z; ((2R,5R)-5-(((5-Fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone; Methanone, [(2R,5R)-5-[[(5-fluoro-2-pyridinyl)oxy]methyl]-2-methyl-1-piperidinyl][5-methyl-2-(2-pyrimidinyl)phenyl]-; Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-methyl-2-(2-pyrimidinyl)phenyl)-; Filorexant [USAN:INN]; Filorexant (USAN); Filorexant(mk-6096); MK-6096; Filorexant; GTPL4460
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Insomnia DIS0AFR7 7A00-7A0Z Phase 2 [1]
Diabetic neuropathy DISX6VF8 8C0Z Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01021852) Polysomnography Study of MK6096 in Patients With Primary Insomnia (6096-011). U.S. National Institutes of Health.